Emami (531162) Aandelenoverzicht
Emami Limited produceert en verkoopt persoonlijke en gezondheidsproducten in India en daarbuiten. Meer informatie
| Sneeuwvlok Score | |
|---|---|
| Waardering | 3/6 |
| Toekomstige groei | 2/6 |
| Prestaties in het verleden | 3/6 |
| Financiële gezondheid | 6/6 |
| Dividenden | 6/6 |
Beloningen
Risicoanalyse
Geen risico's gedetecteerd voor 531162 uit onze risicocontroles.
531162 Community Fair Values
Create NarrativeSee what 8 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Emami Limited Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | ₹416.90 |
| 52 Week Hoogtepunt | ₹634.65 |
| 52 Week Laag | ₹376.05 |
| Bèta | 0.15 |
| 1 maand verandering | 6.41% |
| 3 maanden verandering | 4.71% |
| 1 Jaar Verandering | -25.37% |
| 3 jaar verandering | -2.23% |
| 5 jaar verandering | -24.00% |
| Verandering sinds IPO | 17,703.58% |
Recent nieuws en updates
531162: May Board Meeting And Leadership Review Will Support Bullish Outlook
Analysts have trimmed their price target on Emami to ₹545 from about ₹637, citing refreshed assumptions around slightly higher discount rates, more moderate revenue growth, softer profit margins, and a lower future P/E multiple. What’s in the News for Emami Emami has scheduled a Board meeting on May 21, 2026, at 12:00 Indian Standard Time to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.
531162: Trimmed Fair Value And Rich Future P/E Will Shape Measured Outlook
Analysts have trimmed their price target on Emami from ₹425.00 to ₹415.00, reflecting updates to their models that now factor in different assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News A board meeting is scheduled for May 21, 2026, at 12:00 Indian Standard Time to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.
531162: Upcoming May Results And Board Decisions Will Support Bullish Outlook
Analysts have trimmed their fair value estimate for Emami from ₹800 to about ₹745, citing updated assumptions that include slightly higher revenue growth expectations, along with a lower projected profit margin and a reduced future P/E multiple. What's in the News Board meeting scheduled for May 21, 2026, at 12:00 Indian Standard Time to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).Recent updates
531162: May Board Meeting And Leadership Review Will Support Bullish Outlook
Analysts have trimmed their price target on Emami to ₹545 from about ₹637, citing refreshed assumptions around slightly higher discount rates, more moderate revenue growth, softer profit margins, and a lower future P/E multiple. What’s in the News for Emami Emami has scheduled a Board meeting on May 21, 2026, at 12:00 Indian Standard Time to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.531162: Trimmed Fair Value And Rich Future P/E Will Shape Measured Outlook
Analysts have trimmed their price target on Emami from ₹425.00 to ₹415.00, reflecting updates to their models that now factor in different assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News A board meeting is scheduled for May 21, 2026, at 12:00 Indian Standard Time to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.531162: Upcoming May Results And Board Decisions Will Support Bullish Outlook
Analysts have trimmed their fair value estimate for Emami from ₹800 to about ₹745, citing updated assumptions that include slightly higher revenue growth expectations, along with a lower projected profit margin and a reduced future P/E multiple. What's in the News Board meeting scheduled for May 21, 2026, at 12:00 Indian Standard Time to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).531162: Upcoming Results And Higher Board Meeting Focus Will Support Bullish Outlook
Analysts have raised their price target on Emami from ₹775.37 to ₹800.00, reflecting updated assumptions around discount rates, revenue growth, profit margins, and future P/E multiples. What's in the News Emami has scheduled a board meeting for May 21, 2026.531162: Interim Dividend Will Be Insufficient To Offset Rich Future P/E
Analysts have cut their price target on Emami from about ₹453 to ₹425, reflecting updated assumptions for slightly higher revenue growth, a marginally higher discount rate, and a lower future P/E multiple. What's in the News Board meeting scheduled for May 21, 2026, to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).531162: Interim Dividend And Revised Assumptions Will Support A Balanced Outlook
Analysts have trimmed their price target on Emami from ₹510 to about ₹453, pointing to updated assumptions around a lower future P/E multiple, an adjusted discount rate, and revised expectations for revenue growth and profit margins. What's in the News The board of directors declared a 2nd interim dividend of ₹6 per equity share of face value ₹1 each, described as 600% on 436,500,000 equity shares for the financial year 2025-26 (Key Developments).531162: Second Interim Dividend Will Support Bullish Long Term Outlook
Analysts have trimmed their price target on Emami by about ₹31 to reflect updated assumptions around fair value, discount rate, revenue growth, profit margin, and future P/E expectations. What's in the News The board approved a second interim dividend of ₹6 per equity share of ₹1 each, equal to 600% on 436,500,000 equity shares for FY 2025-26, with the record date set for 10 February 2026 and payment scheduled on or before 6 March 2026 (Key Developments).531162: February Dividend And Board Review Will Support Bullish Outlook
Analysts have trimmed their fair value estimate for Emami to ₹637 from ₹651, citing slightly adjusted assumptions on discount rate, revenue growth, profit margin and future P/E that point to a marginally more conservative outlook on the stock's valuation. What's in the News A board meeting on 4 February 2026 to review unaudited standalone and consolidated financial results for the quarter ended 31 December 2025 and to consider a 2nd interim dividend for FY 2025-26 (company filing).531162: Interim Dividend And Stable Assumptions Will Support A Balanced Outlook
Analysts have maintained their fair value estimate for Emami at ₹510. They have made only minor adjustments to assumptions such as discount rate, revenue growth, profit margin and future P/E, which feed into the updated price target rationale.531162: Board Review And Interim Dividend Will Shape A Balanced Outlook
Analysts have trimmed their price target for Emami from ₹540.54 to ₹510.00, citing refreshed assumptions that include slight adjustments to revenue growth, profit margins and the future P/E multiple under a marginally lower discount rate. What's in the News Emami has scheduled a board meeting on Feb 04, 2026 to review unaudited standalone and consolidated financial results for the quarter ended 31 December, 2025 (Key Developments).531162: February Board Meeting And Dividend Decision Will Reinforce Bullish Outlook
Analysts have trimmed their price target for Emami slightly to ₹651 from about ₹653. The adjustment reflects small tweaks to their fair value, discount rate, revenue growth and profit margin assumptions, alongside a marginally lower expected future P/E multiple.531162: February Dividend Decision Will Support Bullish Long-Term View
Analysts have made only a minor adjustment to their price view on Emami, with the updated fair value at ₹653.25. A slightly lower discount rate, along with revised assumptions for revenue growth, profit margin, and future P/E, serve to fine tune rather than overhaul the prior framework.531162: Upcoming Dividend Decision Will Support Bullish Long Term Outlook
Analysts have trimmed their price target on Emami from ₹883 to ₹807. This reflects slightly lower margin and valuation expectations that more than offset modestly stronger projected revenue growth and a reduced discount rate.531162: Interim Dividend Decision At November Meeting Will Support Bullish Outlook
Analysts have nudged their price target on Emami slightly higher to align with a fair value of ₹653.25. This reflects marginally lower perceived risk and a steady outlook on growth, margins, and future valuation multiples.531162: Board Will Consider Interim Dividend At November 10 Results Meeting
Analysts have revised their price target for Emami down from ₹697.96 to ₹653.25. They cite updated assessments of the company's growth prospects and valuation metrics as reasons for the change.531162: Board To Weigh Interim Dividend At November 10 Meeting
Analysts have slightly revised their price target for Emami downward from ₹706.24 to ₹697.96. This change reflects minor adjustments in growth and profitability expectations.
Relaunching Fair And Handsome And Capitalizing On Dermicool Innovations Will Propel Earnings Growth
Strategic relaunches and product innovations aim to boost revenue, particularly in Fair and Handsome, Kesh King, Dermicool, and BoroPlus Soft segments.Rendement voor aandeelhouders
| 531162 | IN Personal Products | IN Markt | |
|---|---|---|---|
| 7D | 5.0% | 2.1% | -0.06% |
| 1Y | -25.4% | -6.1% | -2.1% |
Rendement versus industrie: 531162 presteerde slechter dan de Indian Personal Products -sector, die het afgelopen jaar een rendement van -6.1 % opleverde.
Rendement versus markt: 531162 presteerde slechter dan Indian Market, dat het afgelopen jaar een rendement van -2.1 % opleverde.
Prijsvolatiliteit
| 531162 volatility | |
|---|---|
| 531162 Average Weekly Movement | 4.1% |
| Personal Products Industry Average Movement | 6.0% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in IN Market | 9.5% |
| 10% least volatile stocks in IN Market | 4.1% |
Stabiele aandelenkoers: 531162 heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend vergeleken met de Indian markt.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 4% ) van 531162 is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1974 | 3,217 | Harsha Agarwal | www.emamiltd.in |
Emami Limited produceert en verkoopt persoonlijke en gezondheidsproducten in India en internationaal. Het bedrijf levert ayurvedische antiseptische crème, poeder voor stekelige hitte, doodh kesar bodylotion, aloë neem lotion, vasocare plantaardige vaseline, kokosolie, aloë vera gel en hygiëneproducten onder de merknaam Boroplus; cool oil, extra thanda, gold ayurvedic oil, therapy ayurvedic body massage and stress relief oil, maxx cool talc, en cool talc onder het merk Navratna; en balm, balm ultra-power, quick relief roll-on, ortho vedic oil, zalf, relief gel en spray, gezondheidsproducten, pancharishta, nityam, en kesari jivan onder het merk Zandu. Het bedrijf biedt ook glanscrème en onmiddellijke glans gezichtswasgel voor mannen onder het merk Fair and Handsome; haarverzorgingsproducten en shampoo onder het merk Kesh King; balsem onder het merk Mentho Plus; prickly heat poeder onder het merk Dermicool; haarolie, shampoos en conditioners onder het merk Emami 7 Oils in One; deodorants onder het merk HE; haarverf onder de merknaam Emami Diamond Shine; talk onder de merknaam Emami Golden Beauty; herbal fairness cream onder de merknaam Emami Naturally Fair; tandpasta onder de merknaam Ayucare; haarverf en oliën onder de merknaam Emami Gold; en vochtinbrengende crèmes, lotions, zachte crèmes, glycerine crèmes en oliën, vaseline, babyshampoos en andere huidproducten onder de merknaam Cream21.
Emami Limited Samenvatting
| 531162 fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | ₹180.71b |
| Inkomsten(TTM) | ₹7.75b |
| Inkomsten(TTM) | ₹37.80b |
Is 531162 overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| 531162 resultatenrekening (TTM) | |
|---|---|
| Inkomsten | ₹37.80b |
| Kosten van inkomsten | ₹11.38b |
| Brutowinst | ₹26.42b |
| Overige uitgaven | ₹18.66b |
| Inkomsten | ₹7.75b |
Laatst gerapporteerde inkomsten
Mar 31, 2026
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 17.76 |
| Brutomarge | 69.89% |
| Nettowinstmarge | 20.51% |
| Schuld/Eigen Vermogen Verhouding | 4.2% |
Hoe presteerde 531162 op de lange termijn?
Bekijk historische prestaties en vergelijkingDividenden
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/07/02 15:40 |
| Aandelenkoers aan het einde van de dag | 2026/07/02 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2026/03/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Emami Limited wordt gevolgd door 44 analisten. 20 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Parin Tanna | 360 ONE Capital Market Private Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Ajay Thakur | Anand Rathi Shares and Stock Brokers Limited |